SCHEMBL7404235

SCHEMBL7404235

Cc1cc(C(C)Oc2ccc(C(=O)NC3(CC(=O)NO)CCCNC3)cc2)c2ccccc2n1

nearest known ligand 0.60

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 17/20 0.60
ADAMTS4 O75173 3/20 0.60
MMP3 P08254 3/20 0.60
ADAMTS1 Q9UHI8 3/20 0.60
ADAMTS5 Q9UNA0 3/20 0.60
MMP7 P09237 2/20 0.60
MMP8 P22894 2/20 0.60
MMP10 P09238 1/20 0.53
MMP14 P50281 1/20 0.53
MMP15 P51511 1/20 0.53
MMP13 P45452 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7399768 0.95 ADAM17 (0.66) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7399912 0.91 ADAM17 (0.73) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7402528 0.86 ADAM17 (0.56) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7401098 0.86 ADAM17 (0.61) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL6596885 0.85 ADAM17 (0.82) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7397813 0.85 ADAM17 (0.60) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7403315 0.84 ADAM17 (0.74) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7404230 0.84 ADAM17 (0.70) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7401744 0.83 ADAM17 (0.56) ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5
SCHEMBL7405015 0.83 ADAM17 (0.64) ADAM17MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263756-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070734-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed